NDC 60505-0589 – Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution

Brimonidine Tartrate 2 mg/mL; Timolol Maleate 5 mg/mL · Solution · Ophthalmic

Human Prescription Drug 3 recalls

Product NDC60505-0589

Product details

Brand name
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
Generic name
Brimonidine Tartrate and Timolol Maleate
Labeler
Apotex Corp.
Dosage form
Solution
Route
Ophthalmic
Marketing category
ANDA · ANDA091442
Marketed since
October 19, 2022
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Agonist; beta-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution →

Package NDC codes (3)

Package NDCDescriptionSince
60505-0589-11 BOTTLE, DROPPER in 1 CARTON (60505-0589-1) / 5 mL in 1 BOTTLE, DROPPEROct 19, 2022
60505-0589-21 BOTTLE, DROPPER in 1 CARTON (60505-0589-2) / 10 mL in 1 BOTTLE, DROPPEROct 19, 2022
60505-0589-31 BOTTLE, DROPPER in 1 CARTON (60505-0589-3) / 15 mL in 1 BOTTLE, DROPPEROct 19, 2022

Recalls mentioning this NDC

Other Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution products